Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.
Veldt BJ, van der Vliet HJ, von Blomberg BM, van Vlierberghe H, Gerken G, Nishi N, Hayashi K, Scheper RJ, de Knegt RJ, van den Eertwegh AJ, Janssen HL, van Nieuwkerk CM.
Veldt BJ, et al. Among authors: janssen hl.
J Hepatol. 2007 Sep;47(3):356-65. doi: 10.1016/j.jhep.2007.04.018. Epub 2007 Jun 6.
J Hepatol. 2007.
PMID: 17599630
Clinical Trial.